St. Jude Loses Occlutech Heart Implant IP Row In The Hague

Law360, New York (May 29, 2012, 3:30 PM EDT) -- Occlutech GmbH said Tuesday that the Dutch Supreme Court had tossed patent infringement claims brought by a St. Jude Medical Inc. unit over minimally invasive implants used to treat structural heart disease.

The high court, located in The Hague, upheld rulings by a Dutch court of first instance and an appeals court, both of which dismissed claims that Occlutech's cardiac occlusion devices infringed AGA Medical Inc.'s European Patent Number 0808138, according to a Occlutech statement.

Occlutech CEO Tor Peters blasted St. Jude for continuing to pursue...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.